Florida Injectables: How to Verify Physician Oversight

Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery

Key Takeaways for Safer Injectables in Florida

• Physician-supervised injectable care in Florida requires active MD/DO oversight with written protocols, chart reviews, and on-site emergency capability to lower risks such as vascular occlusion.¹
• Many medical spas rely on absent or nominal physician involvement, which correlates with higher complication rates, and Florida enforcement now targets these “paper director” arrangements.
• Patients can protect themselves by confirming AHCA licensure, the medical director’s board certification, chart-review frequency, good-faith exam processes, and documented emergency response times before booking.
• Warning signs include unnamed directors, skipped exams, missing hyaluronidase, and poor training in high-risk injection zones, which together signal inadequate oversight.
• At Mirror Plastic Surgery, board-certified plastic surgeon Dr. Akash Chandawarkar provides active oversight while Ellie Pranckevicius, FNP-BC, delivers concierge-level injectable care; schedule your consultation today to experience physician-supervised safety standards.

Why Florida Injectables Must Involve an Active Physician

Botulinum toxin and dermal fillers function as prescription medications in Florida, not as over-the-counter cosmetics. Injecting neuromodulators such as Botox or dermal fillers in Florida constitutes the practice of medicine, which requires a prescription from a licensed prescriber who has established a genuine practitioner-patient relationship through examination. That legal status shapes what safe, compliant injectable care should look like for every patient.

The risk profile of medspa injectables is well documented. One peer-reviewed study published in Dermatologic Surgery (Almukhtar RM et al., 2024) found that 73% of injectable procedures in Las Vegas medical-spa settings are performed by nonphysicians. Two peer-reviewed studies (Almukhtar et al. 2024 in Dermatologic Surgery; Hogan et al. in Dermatologic Surgery) reported on-site physicians absent at 62% and 81% of medical spas, respectively, during injectable procedures. A peer-reviewed study published in Dermatologic Surgery (Almukhtar RM et al., 2024) found that only 46% of surveyed medical spas notify a medical director or supervising physician when a patient experiences a complication. Many medical directors also lack board certification in dermatology or plastic surgery. When a physician is absent and a complication occurs, the consequences can be severe.

Vascular occlusion, which involves blockage of a blood vessel by misplaced filler, illustrates why active oversight is non-negotiable. Lower complication rates for non-surgical facial injectables cluster in regulated, clinician-led settings that maintain written and rehearsed complication protocols, in-date hyaluronidase on premises, defined escalation pathways to secondary care, and longitudinal training; higher rates cluster in unregulated environments with inadequately trained operators and no on-site emergency capability. The same review identifies the regulatory environment, rather than individual skill alone, as the strongest single predictor of population-level harm.

Florida regulators now treat passive physician involvement as a compliance problem. In 2026, Florida’s Board of Medicine treats “paper director” arrangements, where a physician signs protocols and collects a monthly fee without reviewing charts or being reachable, as active enforcement targets. The “paper MD” pattern is the most-cited issue in 2024–2026 Florida medspa investigations under § 458.348.

Seven Checks to Confirm Your Medical Director Is Truly Involved

Patients can verify real physician oversight by asking clear, documented questions before scheduling injectable treatments. These seven checks reflect Florida-specific statute and current enforcement patterns.

1. Confirm AHCA licensure or a documented exemption. Florida medical spas offering injectables must either hold an AHCA health care clinic license under part X of chapter 400 or maintain a documented exemption, most commonly the practitioner-ownership exemption in section 400.9905(4)(g) requiring wholly licensed-practitioner ownership and active supervision by a practitioner owner. Ask the practice which category applies and request proof.
2. Verify the medical director’s board certification. Florida does not require every medspa medical director to be board-certified or board-eligible in dermatology or plastic surgery; any licensed MD or DO may serve depending on practice location and services provided. Request the physician’s name, then confirm their certification status through the relevant specialty board’s public lookup tool.
3. Request the written supervisory protocol. Florida Statute § 458.348 addresses formal supervisory relationships and notice requirements for emergency medical technicians, paramedics, and advanced practice registered nurses, but it does not set forth rules for physician assistants. A compliant practice can produce a current supervisory protocol that covers injectables when you ask.
4. Ask about chart-review frequency. Most states require medical directors to perform quarterly chart reviews at minimum, and some require monthly reviews for high-risk treatments. Reviews typically cover 10–20% of randomly selected charts plus all new patients, with each review signed, dated, and documented with findings and corrective actions. Ask how often the director reviews charts and request evidence of the log.
5. Confirm the good-faith exam process. In Florida, a Good Faith Exam for prescription injectables such as Botox must be performed by a Florida-licensed physician, an ARNP operating under a written supervisory protocol, or a PA under § 458.347 / § 458.348; an RN may not independently perform a Good Faith Exam for a prescription injectable. Confirm who will perform your exam and how that evaluation occurs before treatment begins.
6. Establish emergency response time. Medical directors must be available to respond within a defined time period, typically 30–60 minutes, for emergencies during practice hours and must maintain clear escalation protocols so staff can reach them immediately for complications such as vascular occlusion during injectable treatments. Ask for the specific response-time commitment in writing.
7. Count how many other practices the director supervises. A physician who directs many medspas yet cannot describe oversight for any of them, or who refuses to commit to specific chart-review, site-visit, or response-time standards, is providing only nominal supervision that regulators now reject. Florida statute also limits the number and location of spas a single director may supervise, so ask how your practice fits within those limits.

How Florida Law Shapes Injector Credentials and Emergency Planning

Florida’s regulatory framework for medspa injectables ranks among the most detailed in the country, and 2025–2026 legislative activity has tightened expectations further. The proposed Florida 2026 Medical Spa Prescription Drug Oversight Act (SB 1728/HB 1429) died in committee and was never enacted, so it imposes no licensing or designation requirements on medspas. Existing AHCA clinic-registration mandates and Board of Medicine supervisory-protocol rules still govern practice.

Injector credentials follow clear statutory lines. APRNs and PAs in Florida may inject Botox and fillers only under a written collaborative protocol (section 464.012 for APRNs) or supervising physician protocol (section 458.347 for PAs) that specifically authorizes neuromodulator and filler administration. For RNs, the standard is stricter: “direct supervision” of RN-administered aesthetic injections requires the supervising physician to be physically present with direct visual observation of the injection, and remote or standby availability does not satisfy this requirement.

Documentation gaps often trigger enforcement. The most-cited deficiency in 2024–2026 Florida medspa inspections involves missing or outdated supervisory documentation, including the § 458.348 protocol, the medical director’s primary practice verification, or the chart review log. Patients ultimately carry the risk created by those missing records.

Emergency-protocol expectations are concrete. A vascular occlusion SOP should spell out the sequence: stop the injection immediately, begin the hyaluronidase protocol under medical direction, apply supportive measures, contact the medical director, and define the threshold for emergency department or specialist referral. The American Society for Dermatologic Surgery Association (ASDSA) Medical Spa Safety Act model legislation calls for states to require medical directors to have training in the procedures being performed, public notification when a physician is not on-site, and mandatory adverse event reporting.

Red Flags That Point to Weak Physician Oversight

Certain patterns, alone or together, suggest that a practice’s medical director involvement is nominal rather than active. Patients can use these signs as a quick screening tool.

• Staff cannot name the medical director or provide their Florida license number on request, which raises immediate concerns about legitimacy.
• The medical director never visits the clinic, reviews charts, or trains staff, creating a classic “rent-a-doc” arrangement that regulators increasingly challenge.
• Staff cannot explain the emergency protocol for vascular occlusion or confirm that hyaluronidase is stocked on-site, and any absence of immediate hyaluronidase access should disqualify a practice from performing fillers.
• The good-faith exam is skipped, delegated to a non-prescriber, or handled through a brief online questionnaire without physician review, which undermines the prescription standard.
• Florida’s Board of Medicine treats paper medical-director arrangements as effectively operating without supervision, which can constitute the unlicensed practice of medicine.
• The injector cannot describe their training in anatomical danger zones or high-risk injection areas such as the glabella, nasal dorsum, or nasolabial folds, suggesting inadequate preparation for complications.
• A December 2025 joint New York City Council and State investigation found that all 15 medical spas examined closely in the five boroughs were performing procedures outside state law, with reported patient harms including burns, infections, sepsis, and hospitalization, and Florida enforcement data mirrors this national pattern.

Ellie Pranckevicius: From Neuroscience ICU to Concierge Injectables

Ellie Pranckevicius, FNP-BC, leads all injectable and non-surgical treatments at Mirror Plastic Surgery, located at 780 4th Ave S, St. Petersburg, FL 33701 (727-361-6515). Her training path is uncommon in aesthetics and directly supports safer injectable care.

Ellie holds a Bachelor’s in Health Science from Boston University and completed a 600-hour aesthetics licensure program with extensive hands-on training. She then earned both her Bachelor’s and Master’s in Nursing from the University of South Florida. Before joining Mirror Plastic Surgery, she spent four years as a nurse in the Neuroscience ICU at Tampa General Hospital, managing critically ill patients in an environment that demands rapid clinical judgment, precise pharmacological knowledge, and immediate complication response. That experience translates to early recognition and management of vascular events during injectable treatments.¹

Her career began in 2019 at a high-end medical spa on Newberry Street in Boston, where she advanced from esthetician to medical esthetician and built a deep understanding of skin physiology. She then layered advanced nursing education and prescriptive authority on top of that foundation. This progression, which includes esthetician training, advanced nursing degrees, ICU critical care, and aesthetic nurse practitioner practice, creates a clinical profile that is rare among medspa injectors. That profile is further strengthened by the physician oversight structure in which she operates.

At Mirror Plastic Surgery, Ellie works under the physician-led oversight of Dr. Akash Chandawarkar, MD, a Harvard-educated physician, Johns Hopkins-trained plastic surgeon, and fellowship-trained aesthetic surgeon at Manhattan Eye Ear & Throat Hospital (MEETH)/Lenox Hill Hospital. Dr. Akash’s board certification in plastic surgery and his direct involvement in clinical governance satisfy Florida’s requirements for active, documented physician oversight of injectable services. Dermatologists and plastic surgeons have the clearest fit for medspa medical director roles because their training overlaps directly with the procedures a medspa performs, making them preferred candidates in competitive, high-acuity markets.

Ellie’s treatment philosophy centers on a holistic, full-face approach to rejuvenation. She focuses on foundational restoration before volume augmentation, which supports smooth transitions across facial regions and reduces the risk of asymmetry or an “overdone” appearance that can follow single-area injections.¹ Her concierge model limits daily appointment volume so each patient receives unhurried assessment and follow-up that high-volume practices often cannot provide. The concierge medical aesthetics model trades high clinic volume for individualized time and attention, resulting in fewer patients per day, longer visits, and direct access to the treating provider between appointments.

Ready to discuss your injectable goals under physician-led care? Connect with Ellie to begin your personalized assessment at Mirror Plastic Surgery.

Essential Questions to Ask Before You Book Injectables

Informed patients use targeted questions to evaluate any injectable provider in Florida. The following list outlines a practical due-diligence baseline.

• Who serves as the medical director, what is their Florida license number, and are they board-certified in dermatology or plastic surgery?
• How often does the medical director review patient charts, and can the practice show a sample of the signed protocol for your planned treatment?
• Who performs your good-faith exam, and what credentials and licenses does that prescriber hold?
• Does the facility stock hyaluronidase, epinephrine, and an AED on-site, and can staff describe the vascular occlusion protocol? Patients should ask whether the facility stocks hyaluronidase, epinephrine, and an automated external defibrillator and what the specific protocol is for vascular occlusion.
• What response time does the medical director commit to if a complication occurs during your treatment?
• How many other medspas does the medical director currently supervise, and how is that oversight structured?
• What training does the injector have in high-risk anatomical zones, and have they managed or drilled a vascular occlusion scenario?

---